Denne siden ble automatisk oversatt og nøyaktigheten av oversettelsen er ikke garantert. Vennligst referer til engelsk versjon for en kildetekst.

Comprehensive Exercise Training Program During Hospitalization for an Acute CF Exacerbation

27. juni 2015 oppdatert av: University of Alabama at Birmingham

The Efficacy of a Standardized Exercise Protocol in Inpatient Care of Patients With Cystic Fibrosis

This protocol was designed to assess if when subjects with CF are admitted to the hospital for a pulmonary exacerbation if a comprehensive exercise program (moderate to high intensity aerobic, resistance, flexibility and balance exercises) was superior to our "usual care intervention (30 min/day of self selected mode and intensity of exercise) in improving aerobic capacity, muscle strength/power, flexibility and balance.

Studieoversikt

Detaljert beskrivelse

This protocol was designed to assess if when subjects with CF are admitted to the hospital for a pulmonary exacerbation if a comprehensive exercise program (moderate to high intensity aerobic, resistance, flexibility and balance exercises) was superior to our "usual care intervention (30 min/day of self selected mode and intensity of exercise) in improving aerobic capacity, muscle strength/power, flexibility and balance.

The experimental group will participate in the following regime:

Day 1 - Evaluation including standardized tests and measures: If Day 1 is a M,W, F, day 2 will constitute: aerobic exercise between 20-30 minutes based on patient tolerance using the appropriate RPE scale (13-15 on Borg with patients ages 13-21, and 6-8 on pictoral CERT with patients ages 6-12)to ensure correct intensity. Choices will include treadmill, stationary bike, game bike, or ambulating at varying intensities throughout hospital; Balance Activities: Standing on bosu ball while performing UE activity (throwing, catching with another ball, Frisbee, etc.). Standing on one leg or B LE's will be determined by patients currently level.

If Day 1 is a Tuesday or Thursday, day 2 will constitute: 5-10 minutes of aerobic activity at warm up level (11-13 on Borg, and 4-6 on PCERT)x resistance training for UE: biceps, triceps, lattisimus, rhomboids/mid-trap, thoracic expansion exercises, and other muscles based on patient needs; resistance training for LE: quadriceps, hamstrings, gluteals (especially maximus and medius), and other muscles depending on patient need, core and abdominal strengthening, Stretches for flexibility depending on the patients individual needs: Thoracic expansion stretches will be done with every pt. supine and sidelying. Stretches are held for 10 seconds and repeated 10 times, Hamstring stretches will be performed if pt unable to reach line with sit and reach test.

Studietype

Intervensjonell

Registrering (Faktiske)

23

Fase

  • Ikke aktuelt

Kontakter og plasseringer

Denne delen inneholder kontaktinformasjon for de som utfører studien, og informasjon om hvor denne studien blir utført.

Studiesteder

    • Alabama
      • Birmingham, Alabama, Forente stater, 35233
        • University of Alabama at Birmimgham

Deltakelseskriterier

Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.

Kvalifikasjonskriterier

Alder som er kvalifisert for studier

6 år til 21 år (Barn, Voksen)

Tar imot friske frivillige

Nei

Kjønn som er kvalifisert for studier

Alle

Beskrivelse

Inclusion Criteria:

  • age 6 to 21 years
  • admission for an acute Cystic fibrosis (CF) exacerbation
  • forced expiratory volume in 1 s (FEV1) of < 60% of predicted at admission

Exclusion Criteria:

  • medically unstable as deemed by the attending physician
  • had completed both arms of the present study

Studieplan

Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.

Hvordan er studiet utformet?

Designdetaljer

  • Primært formål: Behandling
  • Tildeling: Randomisert
  • Intervensjonsmodell: Crossover-oppdrag
  • Masking: Ingen (Open Label)

Våpen og intervensjoner

Deltakergruppe / Arm
Intervensjon / Behandling
Eksperimentell: Comprehensive exercise program
Moderate to high intensity aerobic, resistance, flexibility, posture and balance exercise program
Aktiv komparator: Usual care exercise
30 minutes/day of self selected mode and intensity of aerobic exercise

Hva måler studien?

Primære resultatmål

Resultatmål
Tidsramme
Aerobic capacity following intervention of a comprehensive excercise training program
Tidsramme: Participants will be followed for the duration of hospital stay, average number of days 10 (range 4 - 20 days)
Participants will be followed for the duration of hospital stay, average number of days 10 (range 4 - 20 days)

Sekundære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Muscle strength and power following intervention of a comprehensive excercise training program
Tidsramme: Participants will be followed for the duration of hospital stay, average number of days 10 (range 4 - 20 days)
Assessed with arm curl test, partial curl up test, timed 10 repetition sit to stand test
Participants will be followed for the duration of hospital stay, average number of days 10 (range 4 - 20 days)
Posture/flexibility following intervention of a comprehensive excercise training program
Tidsramme: Participants will be followed for the duration of hospital stay, average number of days 10 (range 4 - 20 days)
Assessed with humeral distance, shoulder flexion range of motion, and hamstring length
Participants will be followed for the duration of hospital stay, average number of days 10 (range 4 - 20 days)
Balance following intervention of a comprehensive excercise training program
Tidsramme: Participants will be followed for the duration of hospital stay, average number of days 10 (range 4 - 20 days)
Assessed with the pediatric Berg balance scale
Participants will be followed for the duration of hospital stay, average number of days 10 (range 4 - 20 days)

Samarbeidspartnere og etterforskere

Det er her du vil finne personer og organisasjoner som er involvert i denne studien.

Etterforskere

  • Hovedetterforsker: John D Lowman, PT, PhD, University of Alabama at Birmingham

Studierekorddatoer

Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.

Studer hoveddatoer

Studiestart

1. april 2008

Primær fullføring (Faktiske)

1. oktober 2008

Studiet fullført (Faktiske)

1. oktober 2008

Datoer for studieregistrering

Først innsendt

21. desember 2012

Først innsendt som oppfylte QC-kriteriene

30. desember 2012

Først lagt ut (Anslag)

3. januar 2013

Oppdateringer av studieposter

Sist oppdatering lagt ut (Anslag)

30. juni 2015

Siste oppdatering sendt inn som oppfylte QC-kriteriene

27. juni 2015

Sist bekreftet

1. desember 2012

Mer informasjon

Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .

Abonnere